WallStreetZenWallStreetZen

NASDAQ: ORTX
Orchard Therapeutics PLC Stock Ownership - Who owns Orchard Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Orchard Therapeutics PLC insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Frank E. ThomasTitle President Chief Operating Officer2023-03-1020,000$0.46
$9.18kBuy
Frank E. ThomasTitle President Chief Operating Officer2023-02-0920,000$0.46
$9.18kBuy

1 of 1

ORTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ORTX insiders and whales buy or sell their stock.

ORTX Shareholders

What type of owners hold Orchard Therapeutics PLC stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Glaxosmithkline PLC4.88%12,455,252$64.39MInsider
Ra Capital Management LP3.57%9,111,848$47.11MInsider
Fmr LLC3.21%8,199,080$42.39MInsider
Federated Hermes Inc0.75%1,925,377$9.95MInstitution
Deep Track Capital LP0.46%1,166,670$6.03MInstitution
Chi Advisors LLC0.31%785,738$4.06MInstitution
Temasek Holdings Private Ltd0.17%431,904$2.23MInstitution
Bobby Gaspar0.14%368,158$1.90MInsider
Deerfield Management Company LP Series C0.12%316,169$1.63MInstitution
Citigroup Inc0.07%167,732$867.17kInstitution

1 of 3

ORTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ORTX2.20%11.92%Net BuyingNet Buying
MIST62.60%37.40%Net Buying
YS12.96%0.00%
GRTX43.63%38.93%Net BuyingNet Buying
EPIX72.21%27.79%Net Buying
View Top Biotech Stocks

Orchard Therapeutics Stock Ownership FAQ

Who owns Orchard Therapeutics?

Orchard Therapeutics (NASDAQ: ORTX) is owned by 2.20% institutional shareholders, 11.92% Orchard Therapeutics insiders, and 85.87% retail investors. Glaxosmithkline PLC is the largest individual Orchard Therapeutics shareholder, owning 12.46M shares representing 4.88% of the company. Glaxosmithkline PLC's Orchard Therapeutics shares are currently valued at $64.39M.

If you're new to stock investing, here's how to buy Orchard Therapeutics stock.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.